Parisi Theodora

Parisi Theodora Internist

Education & Academic Qualifications

  • University of Patras Medical School, Medical Degree (1999)
  • University of Athens Medical School, Department of Clinical Therapeutics, General Hospital “Alexandra”, Specialization in Internal Medicine (2003-2008)

 

Doctoral thesis

  • Master of Science (MSc.) in Immunology, Postgraduate Program in “Basic Medical Sciences” of the University of Patras Medical School (2001-2003)

  • aUniversity of Athens Medical School, PhD Thesis: “Study on blood glucose and blood pressure variations during the acute phase of ischaemic stroke” (in process)

 

Fellowship in Societies, Membership in Journal Editorial Committees

  • Athens Medical Association

  • Hellenic Society of Internal Medicine

  • Hellenic Association for the Study of Liver Diseases

 

Work Experience

  • General Prefectural Hospital of Aegion, Aegion (2001)

  • General Hospital “Ag. Andreas”, Patras, Cardiology Department (2000-2001)

  • General Hospital “Alexandra”, Department of Clinical Therapeutics (2003-2008)

  • Hygeia Hospital, Department of Internal Medicine, Attending Physician (2009-present)

  • Private practice (2009-present)

 

Clinical & Research Interest

Clinical Interest:

  • Immunology

  • Preventive Medicine

  • Infectious Diseases

  • Evidenced based medicine

  • Geriarics

Research Interest:

  • AVERROES study (NCT00496769): “Αpixaban VErsus aspirin [acetyl salicylic acid- ASA] to Reduce the Rate Of Embolic Stroke”

  • Biochemical markers modulation in various Infectious Diseases

 

Recent Publications

  • Clinical and Laboratory findings in patients with Influenza during the period 2012-2013. Cako A, Parissi T, Fanis P, Doukas C, Georgilis K. 14th Annual Panhellenic Congress of the Hellenic Society of Infectious Diseases. Athens, March 2014.

  • Hydrochlorothiazide causes dilatation of the penile cavernosal arteries [abstract] G. Rammos, K. Syrgiannis, V. Peppes, E. Feida, T. Parisi, N. Kokolakis, N. Zakopoulos. Int Angiology. 2008;27 Suppl 1(3):118.

  • Synthetic peptides mapping to epitopes of the extracellular domain of the Interleukin-2 receptor beta-chain to inhibit T-cell activation. . Parissi T, Chatzantoni K, Deraos S, Matsoukas I, Mouzaki A. Tranplant Proc. 2004Jul- Aug;36(6):1723-7

  • Synthetic peptides mapping to epitopes of the extracellular domain of the Interleukin-2 receptor beta-chain to inhibit T-cell activation. Parissi T, Chatzantoni K, Deraos S, Matsoukas I, Mouzaki A. Immunology Lett. 2003 Jun 2;87(1-3):1-351